Where do Royalty Pharma's ratios come from?

Every ratio is computed from Royalty Pharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Royalty Pharma RPRX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Operating margin	65.1%-0.5pp	65.6%+0.4pp	65.2%-14.6pp	79.8%-4.1pp	83.9%+26.8pp
Net margin	33.9%+1.4pp	32.5%-0.1pp	32.6%-11.7pp	44.3%-4.0pp	48.3%+10.4pp
Returns
Return on equity	8.4%+0.7pp	7.7%0.0pp	7.7%-2.9pp	10.6%-0.5pp	11.1%+2.7pp
Return on assets	4.4%+0.3pp	4.1%0.0pp	4.1%-1.6pp	5.7%-0.8pp	6.5%+1.5pp
Return on invested capital	9.2%+0.3pp	8.9%0.0pp	8.9%-2.5pp	11.3%-0.7pp	12.1%+4.2pp
Efficiency
Asset turnover	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Liquidity
Current ratio	2.7×+0.3×	2.4×-1.1×	3.5×+2.2×	1.3×-0.3×	1.6×+0.1×
Quick ratio	2.7×+0.3×	2.4×-1.1×	3.5×+2.2×	1.3×-0.3×	1.6×+0.1×
Cash ratio	1.1×+0.1×	1×-0.8×	1.8×+1.2×	0.5×-0.4×	0.9×+0.2×
Leverage
Debt-to-equity	0.9×0.0×	0.9×0.0×	0.9×+0.1×	0.8×+0.1×	0.8×0.0×
Debt-to-assets	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.4×0.0×	0.4×0.0×
Interest coverage	4.7×-0.3×	5.1×-0.4×	5.5×-1.4×	6.9×-0.8×	7.7×+2.0×
Per Share
Book value per share	$17.85+3.7%	$17.21+0.1%	$17.19+1.7%	$16.90-0.1%	$16.91-2.8%
Valuation
Market capitalization	$20.55B+24.5%	$16.51B+8.2%	$15.25B+0.2%	$15.23B+12.9%	$13.49B+19.0%
Enterprise value	$28.94B+16.4%	$24.86B+6.8%	$23.28B+2.9%	$22.62B+13.0%	$20.02B+11.1%
Price / earnings	24.8×+3.5×	21.4×+1.5×	19.9×+5.0×	14.9×+2.6×	12.3×-0.9×
Price / sales	8.4×+1.5×	6.9×+0.5×	6.5×-0.1×	6.6×+0.6×	6×+1.0×
Price / book	2.1×+0.4×	1.7×+0.1×	1.6×0.0×	1.6×+0.2×	1.4×+0.3×
EV / sales	11.9×+1.4×	10.5×+0.5×	9.9×+0.1×	9.8×+1.0×	8.8×+0.9×
Earnings yield	4%-0.7pp	4.7%-0.3pp	5%-1.7pp	6.7%-1.4pp	8.1%+0.5pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Royalty Pharma.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Royalty Pharma's ratios come from?: Every ratio is computed from Royalty Pharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.